Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the skin.

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with type 2 diabetes. While some GLP-1 agonists are used for weight loss in ...

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes and reduce certain heart risks. Its mechanism of action is mimicking a natural hormone (GLP-1) that manages your blood ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades.

liraglutide (marketed as Victoza), will impact the blood sugar levels of teenage and young adult type 1 diabetic patients currently treated with insulin alone. The researchers are currently recruiting ...

Intensive management of diabetes pays fewer dividends as patients ... She faithfully injects her prescribed drug, Victoza, about three times a week and watches her diet. She’s the oldest member ...

Kidney transplant recipients with type 2 diabetes treated with a new class ... Wegovy, Saxenda, Victoza, and Trulicity. It remained unclear, however, whether physicians should prescribe the ...